An 18-month Prospective Natural History Study to Gain Insight Into FSHD2 Pathophysiology and Disease Progression

Recruiting

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(9 sites)

Belgium

Leuven University, Leuven

France

Nice University Hospital, Nice, Alpes M

APHM, Marseille, Bouches du Rhone

Myology Institute, Paris, Paris

Italy

Gemelli University Hospital, Rome, Lazio

Nemo Center, Milan, Lombardy

Pisa University, Pisa, Tuscany

Netherlands

Radboud University Medical Centre Nijmegen, Nijmegen

Spain

Donostia University Hospital, Donostia / San Sebastian, Guipuscoa